This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Depodur vs Fentanyl Infusion for Post-C/S Analgesia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2008 by Goodman, Evan, M.D..
Recruitment status was:  Not yet recruiting
Information provided by:
Goodman, Evan, M.D. Identifier:
First received: September 29, 2008
Last updated: NA
Last verified: September 2008
History: No changes posted
Epidurally administered Depodur provides equal or superior analgesia as an epidural infusion of fentanyl for the first 48 hours after a cesarean section.

Condition Intervention
Analgesia Drug: Depodur Drug: Fentanyl

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Comparison of Single Dose Depodur With Fentanyl Infusion for Post-Cesarean Section Analgesia

Resource links provided by NLM:

Further study details as provided by Goodman, Evan, M.D.:

Primary Outcome Measures:
  • Degree of analgesia (measured on a 10-point scale) [ Time Frame: 48 hours post-operatively ]

Secondary Outcome Measures:
  • Frequency of minor side effects, such as pruritis or nausea. [ Time Frame: 48 hours postoperatively ]

Estimated Enrollment: 300
Study Start Date: October 2008
Estimated Study Completion Date: June 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Epidural Depodur after epidural lidocaine
Drug: Depodur
Depodur 10mg given epidurally at end of cesarean section.
Active Comparator: 2
Epidural Depodur after spinal bupivacaine
Drug: Depodur
Depodur 10mg given epidurally at end of cesarean section after patient received spinal bupivacaine at the beginning of the case.
Active Comparator: 3
Epidural fentanyl infusion after epidural lidocaine or spinal bupivacaine
Drug: Fentanyl
Epidural fentanyl infusion started after epidural lidocaine or spinal bupivacaine used for the cesarean section.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy pregnant women (ASA I or II) who are scheduled for an elective cesarean section
  • Patient appropriate for regional anesthesia
  • Patient agrees to receive regional anesthesia
  • Patient willing to have an epidural infusion of medication for two days postoperatively

Exclusion Criteria:

  • Morbid obesity
  • History of sleep apnea
  • Allergy to opioids medications
  • History of opioids use during week prior to procedure
  • Emergency cesarean section
  • Significant surgical complications
  • Contraindication or refusal to have regional anesthesia
  • Age less than 18
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00762554

United States, Ohio
University Hospitals Case Medical Center Not yet recruiting
Cleveland, Ohio, United States, 44106
Contact: Evan Goodman, MD    216-844-5300   
Contact: Susan Dumas, MD    2168447330   
Principal Investigator: Evan Goodman, MD         
Sponsors and Collaborators
Goodman, Evan, M.D.
  More Information

Responsible Party: Evan Goodman, MD, University Hospitals Case Medical Center Identifier: NCT00762554     History of Changes
Other Study ID Numbers: goodman-1
Study First Received: September 29, 2008
Last Updated: September 29, 2008

Keywords provided by Goodman, Evan, M.D.:
cesarean section
Post-cesarean section analgesia

Additional relevant MeSH terms:
Perceptual Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Adjuvants, Anesthesia
Anesthetics, Intravenous
Anesthetics, General processed this record on September 21, 2017